Home

Reporting, Metrics & Accountability

Our patient recruitment strategies are backed by hundreds of programs, reporting and metrics. Read more...

The Leaders in Global Patient Recruitment

Only CSSi is the authority on global patient recruitment. Across all demographics, and all therapeutic areas. Read more...

Local Enrollment Specialists™

CSSi Local Enrollment SpecialistsTM increase performance at the site, making an impact for the entire program. Read more...

Mission and Vision

Mission

The mission of CSSi is to provide innovative patient enrollment and retention planning and performance designed to exceed our client's expectations. We achieve this mission by addressing the key factors in a successful patient recruitment campaign: the right strategy for the protocol and the right tools to complete enrollment on time and on budget.

 

Vision

CSSi is an advocate of patients receiving the highest quality of medical care while enrolled in a clinical trial. Our goal is to help our clients conduct efficient and quality clinical trials while reducing enrollment timelines and cost by delivering strategic solutions that utilize our expertise in developing site-specific patient recruitment plans.

From Guinea Pigs to Contributor to the World’s Health: Changing the Negative Perception of Clinical Research

From Guinea Pigs to Contributor to the World’s Health:  Changing the Negative Perception of Clinical Research

“What do you do for a living?,” my hair stylist asked. “I work for a patient recruitment company. We recruit patients who are eligible to participate in clinical trials,” I answered. “So – you find the guinea pigs?,” she replied.  I was left speechless.

This encounter made me realize that much needs to be done to improve the public’s perception of clinical research. Randomized clinical trials provide valid assessments of the safety and efficacy of treatments, diagnostics, and preventive therapies. Trial results can revolutionize current treatments for the most widespread chronic diseases and conditions and for the rarest of diseases.  They also play an important role in the development of preventive care and vaccines.

Yet a major obstacle to clinical research is the low numbers of individuals who enroll due to negative public perceptions about clinical research.  The healthcare research industry and the general public could work together to dispel the notion of “guinea pig” and replace it with the notion of “contributor to the world’s health.”  Below are some approaches that could help this initiative.

Education

Teaching basic medical vocabulary and the principles of clinical research in high schools could result in better understanding of clinical trials. This could translate to greater participation for the students themselves as they enter young adulthood as well as for their parents as they age.

Improved Public Awareness through Advocacy Groups

Advocacy groups have played an important role in promoting involvement in research for a variety of diseases.  The National Foundation for Infantile Paralysis pioneered public support for clinical research after World War II through the March of Dimes. This tradition continues with the “Love/Avon Army of Women” which enlists participants in breast cancer trials in collaboration with the American Association for Cancer Research and the National Breast Cancer Coalition. Many disease-specific organizations are successfully bringing awareness of clinical research by connecting with patients who suffer from a variety of diseases such as arthritis, cancer, and diabetes.

Public Health Service Messages

Educating individuals about clinical trials can improve perceptions about research studies and might increase their willingness to enroll or tell friends or family members about an appropriate trial. These messages could stress that modern safeguards have been implemented to protect participants.

Improve Study Volunteer Experiences with Effective Communication

The study coordinator plays a vital role in how a patient views their clinical research experience. Patients want to be told of the benefits and risks. They want to know the relevance of the study to themselves and they want to be treated with empathy. They also want to know that their privacy and confidentiality are being protected.  Perhaps they could be given a pin to signify their involvement creating a sense of pride which might lead them to recommend clinical trials to others.

Everyone Can Do their Part

Many of today’s most effective prevention and treatment methods were tested and proven in clinical trials and are now accepted as the standard of care. We are all fortunate to have these treatments and therapies. We can all do our part to change the negative perceptions of clinical research.

The next time my hairstylist or anyone else speaks negatively about clinical research, I will respond by saying, “No, we do not recruit guinea pigs. We recruit contributors to the world’s health.”

 

 

Join the CSSi Community

We're always on top of industry news, current trends and the always evolving clinical research landscape. Stay up-to-date with the latest observations, news and updates from the CSSi patient recruitment experts.

Subscribe! Learn from us! Ask questions!

CSSi Announces the Establishment of their Newest Division, CSSi LifeSciences; Will Support All Phases of Pharma Product Lifecycle

June 11, 2014

Glen Burnie, MD– CSSi, the leader in patient recruitment solutions for the clinical research industry, recently announced the formation of the company’s LifeSciences division.  This entity was created to complement our other service offerings by providing guidance and support for all phases of the product life cycle, from product concept and early planning to post approval compliance and surveillance.

CSSi LifeSciences provides innovative solutions which span the entire lifecycle of a new drug or device by reducing time to market, development costs, and resources.  Their portfolio of service offerings includes Health Authority Interactions, Regulatory Consulting, FDA/EMEA Advisory Committee Support, Clinical and Site Planning Services, and Regulatory and Clinical Communications Services. Since 2005, the LifeSciences team members have worked on more than 150 new drugs, biologics, and devices, and have extensive “First in Class” and “First Indication” experience. 

The LifeSciences team is being led by James Sergi, who has held various positions in academic nursing and cancer research, before co-founding and serving as CEO of a healthcare services and drug development company. His academic and medical experience includes Director and Administrator for the Department of Experimental Therapeutics at the Cleveland Clinic Cancer Center, Associate Professor of Medical-Surgical Nursing at the Case Western Reserve University Frances Payne Bolton School of Nursing, Lecturer for Oncology Nursing at the Cleveland State University College of Nursing, and Research Manager of Hematology and Medical Oncology at the Cleveland Veterans Administration Medical Center Research Division.

“The regulatory industry is constantly changing and evolving which presents continued challenges to pharmaceutical companies who are tasked with bringing new drugs to market quickly while maintaining cost efficiency,” states Chris Trizna, President of CSSi. “CSSi is thrilled to bring Jim Sergi on board as President to lead this new division. His extensive experience in the regulatory industry will allow us to increase our global operation capabilities as pharmaceutical companies are relying more on outsourcing regulatory needs to market their new medicines.”  

“CSSi LifeSciences will allow clients to be more effective and knowledgeable when dealing with the complex arena of regulatory operations and affairs.  I am very excited to join CSSi and help them broaden their service offerings to include regulatory information solutions,” commented James Sergi, newly appointed President of CSSi LifeSciences division. “With offices in Baltimore, San Francisco and London, CSSi LifeSciences is positioned to drive successful outcomes for pharmaceutical companies of all sizes and specialties.”

 About CSSi

CSSi delivers global patient recruitment solutions that ensure successful enrollment, on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. For more information on CSSi, visit www.CSSiEnroll.com , or contact Jennifer Whitlock at This email address is being protected from spambots. You need JavaScript enabled to view it. or 443-308-5803.

  •    It was a long journey, and we are all delighted at the successful outcome. We appreciate the support [the CSS] team provided along the way. Hopefully, we can work together again in the future.

    -Sponsor
  •    You have made our advertising so much easier and taken time off my plate, which is always appreciated. We look forward to a prosperous relationship ahead!

    -Investigative Site
  •    …greatly appreciate your help throughout the year. You have taken a significant burden off my shoulders over the past several years.

    -Investigative Site
  •    I cannot begin to express my appreciation for a job well done and the continued efforts you place to ensure that this study was a success! Our candor and transparency has been refreshing and I am fortunate to have partnered with such a great group of patient recruitment and retention experts! You are wonderful!

    -Top 10 CRO
  •     I wanted to take a moment and say thank you for continuing to do a great job and meeting our expectations. I could not be more pleased with the teamwork and efficiency in which you both approach (our) study!

    Top 10 CRO
  •    To begin with, please let yourteam know that everyone is doing a FANTASTIC job with compiling the information for this difficult study.

    -Top 10 CRO
  •    I would not hesitate to use CSS again! Your team has been an absolute pleasure to work with and I consider us friends as well. If you are ever in the Raleigh area, please let me know.

    -Sponsor
  •    We had the phones ringing off the hook for a few days, and we ended with approximately 60 individuals who sounded like viable screeners from the contact list. They are spread out over the next six weeks. Up to this time we have only screened about 30 others (before campaign) had 16 that were cultured and four successfully enrolled, so we are running about 11% from screen appointment to successfully enrolled! By the way, overall this is the best ad response we have ever had!

    -Dermatology Investigator
  •    If this sounds like a "paid advertisement" for CSS, it's not. I just can't say enough good things about how they have helped us grow as a site by putting our name out there in a very professional way. To me it only makes sense to use CSS or a company like them (I just think they are the best one). We are in the business of research, not advertising. Let the experts in advertising handle that job for your site and put your energy into doing what you do best…research.

    -Multi-specialty Investigative Site
  •    It is a PLEASURE working with the CSS team! I could not be more pleased with the progress thus far and feel that the communication and team oriented approach is EXACTLY what we are looking for.

    -Top 10 CRO

Offices and Locations

  • US Address:
    6958 Aviation Blvd
    Suite H
    Glen Burnie, MD 21061
    UK Address:
    London Bioscience Innovation Centre
    2 Royal College Street
    London NW1 0NH
    India Address:
    Plot No. 32-34 & 39-41
    FlatNo.504&506, 4thFloor,
    KTC Illumination,
    GafoorNagar,
    Madhapur,HitechCity,
    Hyderabad–500081